Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer.

Sci Rep · 2018 · PMC6237923 · PMID 30442983

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We could also demonstrate a statistically highly significant correlation between PITX2 DNA methylation (therascreen PITX2 RGQ PCR assay equivalent PMR data with PMR equiv = 12) and clinical outcome (DFS) for patients treated with anthracycline-based chemotherapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.